. (TRIV)
$5.87 - (-)
Market Cap: -
As of 12/31/18 12:00 AM EST. Market closed.
. (TRIV)
$5.87
- (-)
Market Cap: -
As of 12/31/18 12:00 AM EST. Market closed.
Add to Portfolio
COMPANY PROFILE
Sector
Industry
URL
Address
.
Sector
Industry
URL
Address
.
PRICE CHART FOR
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
-
Previous Close
$5.87
Days Range
- - -
52 week range
- - -
Volume
0
Avg. Volume (30 days)
0
Market Cap
-
Dividend Yield
-
P/E
-
Shares Outstanding
0
Open
-
Previous Close
$5.87
Days Range
- - -
52 week range
- - -
Volume
0
Avg. Volume (30 days)
0
Market Cap
-
Dividend Yield
-
P/E
-
Shares Outstanding
0
FINANCIAL STATEMENTS FOR
LOADING...
Open in: 
Open in:
INSIDER TRANSACTIONS FOR
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| Thomas Robert | Director | Feb 03, 2016 | Option Exercise | $5.62 | 7,145 | 40,155 | 99,494 | Feb 04, 2016, 04:45 PM |
| Thomas Robert | Director | Feb 03, 2016 | Option Exercise | $2.43 | 16,523 | 40,151 | 106,639 | Feb 04, 2016, 04:45 PM |
| Moore Daniel Jeffrey | Director | Feb 03, 2016 | Option Exercise | $5.62 | 6,772 | 38,059 | 8,889 | Feb 04, 2016, 04:43 PM |
| Moore Daniel Jeffrey | Director | Feb 03, 2016 | Option Exercise | $2.43 | 15,661 | 38,056 | 15,661 | Feb 04, 2016, 04:43 PM |
| O'Quinn Shari L | VP Clinical/Regulatory Affairs | Feb 03, 2016 | Option Exercise | $5.62 | 21,641 | 121,622 | 23,746 | Feb 04, 2016, 04:42 PM |
| O'Quinn Shari L | VP Clinical/Regulatory Affairs | Feb 03, 2016 | Option Exercise | $2.43 | 41,838 | 101,666 | 41,838 | Feb 04, 2016, 04:42 PM |
| Jayaraman Vivek K | VP Global Sales and Marketing | Feb 03, 2016 | Option Exercise | $5.62 | 26,126 | 146,828 | 33,351 | Feb 04, 2016, 04:41 PM |
| Jayaraman Vivek K | VP Global Sales and Marketing | Feb 03, 2016 | Option Exercise | $2.43 | 47,778 | 116,101 | 54,048 | Feb 04, 2016, 04:41 PM |
| Elting Kimberley A. | VP, Gen. Counsel and Secretary | Feb 03, 2016 | Option Exercise | $5.62 | 40,533 | 227,795 | 30,105 | Feb 04, 2016, 04:40 PM |
| Elting Kimberley A. | VP, Gen. Counsel and Secretary | Feb 03, 2016 | Option Exercise | $3.25 | 61,621 | 200,268 | 65,740 | Feb 04, 2016, 04:40 PM |
| Chobotov Michael V. | Chief Technology Officer | Feb 03, 2016 | Option Exercise | $5.62 | 20,502 | 115,221 | 181,151 | Feb 04, 2016, 04:37 PM |
| Chobotov Michael V. | Chief Technology Officer | Feb 03, 2016 | Option Exercise | $2.43 | 22,137 | 53,793 | 196,224 | Feb 04, 2016, 04:37 PM |
| Chavez Christopher G. | President, CEO and Chairman | Feb 03, 2016 | Option Exercise | $5.62 | 44,714 | 251,293 | 720,120 | Feb 04, 2016, 04:36 PM |
| Chavez Christopher G. | President, CEO and Chairman | Feb 03, 2016 | Option Exercise | $3.25 | 29,720 | 96,590 | 689,672 | Feb 04, 2016, 04:36 PM |
| Kramer Michael R | Chief Financial Officer | Feb 03, 2016 | Option Exercise | $5.62 | 13,799 | 77,550 | 101,103 | Feb 04, 2016, 04:35 PM |
| Kramer Michael R | Chief Financial Officer | Feb 03, 2016 | Option Exercise | $2.43 | 16,032 | 38,958 | 108,341 | Feb 04, 2016, 04:35 PM |
| ROEDER DOUGLAS A | Director | Apr 22, 2014 | Buy | $12.00 | 833,333 | 9,999,996 | 833,333 | Apr 24, 2014, 04:05 PM |
| Delphi Management Partners VIII, L.L.C. | 10% Owner | Apr 22, 2014 | Buy | $12.00 | 833,333 | 9,999,996 | 833,333 | Apr 24, 2014, 04:04 PM |
| DRANT RYAN D | Director | Apr 22, 2014 | Buy | $12.00 | 583,333 | 6,999,996 | 583,333 | Apr 24, 2014, 02:59 PM |
| New Enterprise Associates 12, Limited Partnership | 10% Owner | Apr 22, 2014 | Buy | $12.00 | 583,333 | 6,999,996 | 583,333 | Apr 24, 2014, 02:58 PM |
| Flynn James E | 10% Owner | Apr 22, 2014 | Buy | $12.00 | 340,425 | 4,085,100 | 593,809 | Apr 22, 2014, 05:16 PM |
| Flynn James E | 10% Owner | Apr 22, 2014 | Buy | $12.00 | 297,075 | 3,564,900 | 518,193 | Apr 22, 2014, 05:16 PM |
| Flynn James E | 10% Owner | Apr 22, 2014 | Buy | $12.02 | 189,810 | 2,280,794 | 261,143 | Apr 22, 2014, 05:16 PM |
| Flynn James E | 10% Owner | Apr 22, 2014 | Buy | $12.02 | 237,690 | 2,856,129 | 324,524 | Apr 22, 2014, 05:16 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
| Owner | Relationship | Date | Value($) |
| Thomas Robert | Director | 02/03/2016 | 40,155 |
| Thomas Robert | Director | 02/03/2016 | 40,151 |
| Moore Daniel Jeffrey | Director | 02/03/2016 | 38,059 |
| Moore Daniel Jeffrey | Director | 02/03/2016 | 38,056 |
| O'Quinn Shari L | VP Clinical/Regulatory Affairs | 02/03/2016 | 121,622 |
| O'Quinn Shari L | VP Clinical/Regulatory Affairs | 02/03/2016 | 101,666 |
| Jayaraman Vivek K | VP Global Sales and Marketing | 02/03/2016 | 146,828 |
| Jayaraman Vivek K | VP Global Sales and Marketing | 02/03/2016 | 116,101 |
| Elting Kimberley A. | VP, Gen. Counsel and Secretary | 02/03/2016 | 227,795 |
| Elting Kimberley A. | VP, Gen. Counsel and Secretary | 02/03/2016 | 200,268 |
| Chobotov Michael V. | Chief Technology Officer | 02/03/2016 | 115,221 |
| Chobotov Michael V. | Chief Technology Officer | 02/03/2016 | 53,793 |
| Chavez Christopher G. | President, CEO and Chairman | 02/03/2016 | 251,293 |
| Chavez Christopher G. | President, CEO and Chairman | 02/03/2016 | 96,590 |
| Kramer Michael R | Chief Financial Officer | 02/03/2016 | 77,550 |
| Kramer Michael R | Chief Financial Officer | 02/03/2016 | 38,958 |
| ROEDER DOUGLAS A | Director | 04/22/2014 | 9,999,996 |
| Delphi Management Partners VIII, L.L.C. | 10% Owner | 04/22/2014 | 9,999,996 |
| DRANT RYAN D | Director | 04/22/2014 | 6,999,996 |
| New Enterprise Associates 12, Limited Partnership | 10% Owner | 04/22/2014 | 6,999,996 |
| Flynn James E | 10% Owner | 04/22/2014 | 4,085,100 |
| Flynn James E | 10% Owner | 04/22/2014 | 3,564,900 |
| Flynn James E | 10% Owner | 04/22/2014 | 2,280,794 |
| Flynn James E | 10% Owner | 04/22/2014 | 2,856,129 |
Load More Insider Transactions
BUYBACK ANNOUNCEMENT(S) FOR
LOADING...